By evaluating VDJ regions across all three samples we observed >99% of all B cells (CD79A+) sequenced contained identical VDJ sequences, confirming the RT-phase tumor in this patient derived as a clonal progression from the existing CLL (Supplemental Fig. 1A). Here, CD79A is linked to neoplasm.